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Abstract
The generation of affinity reagents, usually monoclonal antibodies, remains a critical bottleneck in biomedical research and
diagnostic test development. Recombinant antibody-like proteins such as scFv have yet to replace traditional monoclonal
antibodies in antigen detection applications, in large part because of poor performance of scFv in solution. To address this
limitation, we have developed assays that use whole yeast cells expressing scFv on their surfaces (yeast-scFv) in place of
soluble purified scFv or traditional monoclonal antibodies. In this study, a nonimmune library of human scFv displayed on
the surfaces of yeast cells was screened for clones that bind to recombinant cyst proteins of Entamoeba histolytica,a n
enteric pathogen of humans. Selected yeast-scFv clones were stabilized by lyophilization and used in detection assay
formats in which the yeast-scFv served as solid support-bound monoclonal antibodies. Specific binding of antigen to the
yeast-scFv was detected by staining with rabbit polyclonal antibodies. In flow cytometry-based assays, lyophilized yeast-
scFv reagents retained full binding activity and specificity for their cognate antigens after 4 weeks of storage at room
temperature in the absence of desiccants or stabilizers. Because flow cytometry is not available to all potential assay users,
an immunofluorescence assay was also developed that detects antigen with similar sensitivity and specificity. Antigen-
specific whole-cell yeast-scFv reagents can be selected from nonimmune libraries in 2–3 weeks, produced in vast quantities,
and packaged in lyophilized form for extended shelf life. Lyophilized yeast-scFv show promise as low cost, renewable
alternatives to monoclonal antibodies for diagnosis and research.
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Introduction
Defined as antibody (Ab)-like molecules that bind to specific
antigens, affinity reagents are critical tools in biomedical research,
biomarker discovery, and diagnostic testing. Generation of
monoclonal antibodies (MAbs) by traditional methods, typically
by the mouse hybridoma route, is a significant bottleneck in
biomedical research and development. MAbs in diagnostic tests
often require significant optimization before being usable for
diagnostic assays, and licensing costs can exceed all other test costs
combined. Cheaper and more available affinity reagents would
greatly facilitate biomedical research and empower developers of
new diagnostic tests.
Recombinant antibody-like molecules such as single chain
Fragment variable (scFv) and fragment antigen binding (Fab) are
potentially appealing alternatives to MAbs. Libraries of these
molecules have been displayed on the surfaces of organisms
including E. coli, phages, yeast, and on ribosomes. Although these
methods have existed for many years, few such fragments have
proven useful as molecular probes in diagnostic tests. Methods for
rapidly selecting antigen-binding yeast-displayed scFv clones were
described nearly ten years ago [1]. Yeast display libraries express
scFv on the surface of Saccharomyces cerevisiae cells. Using a
combination of magnetic bead enrichment and fluorescent-
activated cell sorting (FACS), yeast clones that bind specifically
to antigens can be selected from naı ¨ve libraries in 2–3 weeks. This
selection process is much faster and less expensive than the mouse
hybridoma route. However, scFv selected by this method rarely
perform well when secreted into solution. Like natural antibodies,
yeast-displayed scFv are products of selection, in this case for
activity in the environment of a yeast cell surface. Hence, many
yeast-displayed scFv perform poorly in other environments,
especially when secreted. Although functional soluble scFv have
been reported [2,3,4,5,6,7,8], in practice the great majority of scFv
culled from yeast display libraries have exhibited unsatisfactory
activity in standard immunoassay formats.
One solution to this problem is to forgo the generation of
soluble scFv, and instead use the yeast-displayed scFv (yeast-scFv)
directly as detection reagents. In this strategy, the yeast cell
provides a surface on which to present the scFv, which is similar in
nature to a plastic or ceramic bead particle that has been coupled
to an antibody. An example of this strategy was reported by Cho
et al, who used yeast-displayed scFv to immunoprecipitate (IP)
brain endothelial proteins from a complex cell lysate [9]. In this
method, bound proteins were eluted from the yeast cell surface by
mild reduction, and the eluted proteins subjected to mass
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Yeast Display Immunoprecipitation (YDIP) [9]]. Another example
is a competitive-inhibition flow cytometry (CIFC) assay [7]. CIFC
is an indirect assay in which antigen capture is detected and
quantified by competitive inhibition of yeast-scFv binding to
fluorescently labeled antigen.
A disadvantage of both YDIP and CIFC is that yeast-scFv
probes must be cultured and induced to express scFv before each
assay. In addition, YDIP requires mass spectrometry to detect
captured antigens, a potentially cumbersome procedure requiring
significant laboratory instrumentation. CIFC has its own limita-
tions, being an indirect format that is susceptible to false-positive
results due to non-specific inhibition of fluorescent antigen
binding.
The present study sought to overcome these limitations to yield
truly practical, direct yeast-scFv assay formats. Induced yeast-scFv
probes were lyophilized to yield stable reagents that did not
require cultivation or special storage conditions, and were
immediately usable following rehydration. In addition, simple
direct assay formats were developed that used yeast-scFv reagents
in combination with basic laboratory resources.
To evaluate these methods, we isolated yeast-scFv probes that
bound specifically to putative cyst proteins of the parasite
Entamoeba histolytica, the causative agent of intestinal amoebiasis
in developing countries [10,11]. These proteins were previously
shown by gene expression profiling analyses to be up-regulated in
E. histolytica cysts [12], thereby making them candidate stool
biomarkers of E. histolytica infection. The study demonstrates a new
type of renewable affinity reagent that can be selected from non-
immune yeast display libraries in 2–3 weeks, produced in vast
quantities by yeast culture, and packaged in lyophilized form for
extended shelf life.
Results
Library selections
Four E. histolytica proteins were selected for this study on the
basis of their elevated mRNA expression in the cyst stage relative
to the trophozoite stage of the parasite [12]. Fragments of each
protein were selected and cloned to minimize sequence overlap
with homologs from the commensal species E. dispar and E.
moshkovskii. These species are closely related to E. histolytica and are
often found in stool samples, but are not pathogenic to humans
[13,14,15]. The protein fragments, which ranged in size from 12
to 34 kDa, were cloned for expression in E. coli (Table 1). One of
the proteins, EhJacob1, is expressed at approximately 1290 fold
higher mRNA level in the cyst form relative to the trophozoite
form of the parasite [12]. In early encysting E. invadens cells (a
model parasite for studying encystation in E. histolytica), Jacob
proteins appear on the surface of encysting parasite and are
abundant in the walls of mature cysts [16,17]. Three chromodo-
main-containing proteins (EHI_142000, EHI_115350 and EHI_
000780; hereafter termed 142, 350, and 780, respectively) were
also selected because chromodomain proteins fulfill stage-specific
functions in other systems [18,19]. Additionally, 780 was detected
in 2 out of 5 E. histolytica cyst samples that were subjected to
shotgun proteomic analysis (Ali et al., unpublished).
The Wittrup library of human nonimmune scFv antibodies
displayed on the surface of yeast (gift of K. Dane Wittrup,
Massachusetts Institute of Technology) was used to isolate scFv
that bind to E. histolytica proteins. Following magnetic and FACS
selections, sorted clones were tested for binding to cognate antigen
as well as for specificity. To determine specificity, antigen-binding
clones were tested for non-binding to a minimum of four
additional E. histolytica-derived non-cognate antigens.
A total of 48 selected clones were tested to confirm binding to a
biotinylated 350 fragment (350-biotin). Of these, 30 clones
specifically bound the antigen. However, BstN1 fingerprint
analysis followed by DNA sequencing revealed that only two
clones, designated 350-12 and 350-E2, were isolated. Clone 350-
E2 was isolated more than 20 times from multiple sorts with this
antigen. Further characterization of these clones revealed that
350-12 bound only biotinylated-350, and failed to bind unlabeled
350, while clone 350-E2 bound both labeled and unlabeled 350.
For the 780 antigen, eight unique clones were isolated from 48
selected clones. All 8 of these clones bound biotinylated-780, and
none of them bound unlabeled 780 antigen. Biotinylation may
have altered antigen structure such that unlabeled antigen was no
longer recognized. One of the unique clones, designated 780-23,
bound the 780-biotin antigen at a moderately high affinity of
,1 nM as determined by using a flow cytometric assay described
previously [6,7]. This clone was chosen for lyophilization studies.
Selections with the Jacob antigen generated several unique
clones. One clone, designated Jacob-A11, bound to both
biotinylated and unlabeled Jacob antigen. The affinity was
determined to be 43 nM and this clone was selected for further
studies. The 142 fragment generated a panel of yeast scFv that
exhibited good binding. However, all of these scFv exhibited non-
specific binding to at least one of the four non-cognate control
proteins employed for the specificity analysis. No clones were
isolated that bound specifically to 142.
In summary, yeast-scFv clones were isolated that bound
specifically to 3 out of 4 protein fragments examined. The
following 4 yeast-scFv clones that bound specifically to putative E.
Table 1. E. histolytica proteins used in this study.
Protein EHI # NCBI Accession Total AA
1 AA Expressed MW (kDa)
2 Annotation
Yeast-scFv
probe
Jacob EHI_044500 XP_657246 574 323 34 Cyst wall-specific glycoprotein
Jacob1
Jacob-A11
780 EHI_000780 XP_653178 1641 148 19 Chromodomain-helicase-DNA-
binding protein
780-23
350 EHI_115350 XP_649984 1247 138 17 Chromodomain-helicase-DNA-
binding protein
350-E2
350-12
142 EHI_142000 XP_654629 414 117 12 Histone acetyltransferase none
1AA, number of amino acids.
2Calculated molecular weight of expressed protein fragments.
doi:10.1371/journal.pone.0032042.t001
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350-E2 and 350-12 which bound the 350 antigen; clone 780-23
which bound the biotinylated 780 antigen, and clone Jacob-A11
which bound the Jacob antigen.
Yeast-scFv lyophilization and assay formats
Selected yeast clones were induced to express scFv and antigen
binding was confirmed by flow cytometry. The yeast cells were
then lyophilized as described in Materials and Methods. Yeast that
were lyophilized and rehydrated in assay wash buffer appeared
morphologically similar to fresh, pre-lyophilized yeast (Figure 1).
Both pre-lyophilized yeast and reconstituted yeast appeared
rounded and uniform with approximately half of the yeast in the
process of budding. By flow cytometry, forward scatter (FSC)
versus side scatter (SSC) plots indicated slight differences between
fresh and lyophilized yeast. Specifically, yeast that had been
lyophilized and rehydrated shifted to the left on SSC histograms
relative to fresh yeast, while remaining largely unchanged on FSC
histograms. This suggests that lyophilization and rehydration
reduces the complexity and granularity of yeast-scFv cells without
significantly changing their size.
Lyophilized yeast-scFv probes were used in three antigen
detection assay formats. In one format, used primarily for assay
development purposes, biotinylated antigens were captured by
yeast-scFv and bound antigen was then detected by staining with
streptavidin conjugated to phycoerythrin (SA-PE) followed by flow
cytometric analysis (results reported in Figure 2A). In a second,
more broadly useful format, unlabeled antigens were incubated
with yeast-scFv and their capture was detected by incubating the
complexes with rabbit polyclonal antiserum raised against the
antigen. Figure 2B shows the results of rehydrated yeast-350-E2
binding to unlabeled 350 antigen. The antigen-rabbit polyclonal
antibody complex was further detected using a phycoerythrin-
conjugated goat-anti-rabbit MAb (GaR-PE) and analyzed by flow
cytometry. The rabbit polyclonal antiserum was not affinity
purified and therefore was unlikely to be fully specific to the
cognate antigens. However, when such antibodies were used in
sandwich assays in combination with monoclonal yeast-scFv
probes, the combined assays were expected to be specific. In a
third assay format, a sandwich assay incorporating yeast-scFv
capture probes, polyclonal rabbit antibody signal probes and
GaR-FITC detection probes were combined with an immunoflu-
orescence (IFA) microscopy readout rather than flow cytometry.
In the flow cytometry-based assays, binding of antigen was
quantified as the percent of PE-positive yeast relative to the no
antigen control. In most such assays, positive binding resulted in
PE-fluorescence of approximately 45–65% of yeast cells.
Lyophilization and reconstitution had little effect on binding of
yeast-scFv to antigens. For example, freshly grown yeast-scFv 350-
E2 exhibited approximately 53% binding to both unlabeled
(Figure 2B) and biotinylated 350 antigen (Figure 2A) prior to
lyophilization, and approximately 64% binding after lyophilization
and reconstitution. The same probe exhibited only ,6% binding
to three non-cognate antigens (142, Jacob, and 780). This
specificity did not change with lyophilization and rehydration,
although slightly greater background binding to biotinylated non-
cognate antigens was observed in lyophilized yeast. Specifically,
fresh yeast exhibited 0.16–0.27% binding to biotinylated non-
cognate antigens while lyophilized yeast exhibited 3.27–5.15%
binding to these antigens. When unlabeled antigens were detected
using rabbit polyclonal antibody followed by GaR-PE in place of
SA-PE, both fresh and lyophilized yeast exhibited similar
background binding levels. Therefore, it is likely that the SA-PE
reagent is responsible for the non-specific binding seen in
Figure 2A. In addition to clone 350-E2 (Figure 2), full activity
following lyophilization was observed in 8 additional, distinct
yeast-scFv clones specific to 3 different antigens (Figure S1). No
clone examined failed to bind its cognate antigen following
lyophilization. Therefore, antigen-specific binding after lyophili-
zation appears to be a frequent property of yeast-scFv reagents.
While appearing healthy microscopically and retaining scFv
expression and antigen binding, the lyophilized yeast did not
retain viability under the lyophilization conditions used. Attempts
to culture rehydrated cells demonstrated complete loss of viability.
Lower limit of detection (LLD) of lyophilized yeast-scFv
probes
To quantify the sensitivity of antigen detection by yeast-scFv
reagents, we tested the 350-E2probe against 10concentrationsof350
antigen ranging from 20 nM to 0.04 nM in twofold serial dilutions,
each in a volume of 2.5 mL. Bound 350 antigen was detected by
incubation with rabbit anti-350 antiserum followed by GaR-PE and
Figure 1. Morphologies of fresh and lyophilized yeast. Ten microliters of fresh induced (Panel A) or lyophilized and rehydrated (Panel B) yeast-
scFv clone 350-E2 was analyzed by light microscopy at 406magnification.
doi:10.1371/journal.pone.0032042.g001
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approximately310 picomolar, comparable to an ELISA assay using a
typical monoclonal antibody. The LLD was determined as the
concentration of antigen resulting in binding was two standard
deviations above the ‘‘no antigen’’ negative control.
Immunofluorescence microscopy assay using yeast-scFv
probes
The flow cytometry-based assays are sensitive and specific;
however, flow cytometry capabilities are not available to all
potential users of yeast-scFv probes. Therefore, we developed an
alternative immunofluorescence microscopy assay (IFA) using
lyophilized yeast-scFv. To evaluate the IFA, the reconstituted
yeast-scFv (350-E2 in Figure 4) were incubated with antigen in a
concentration series ranging from 500 nM to 0.69 nM in threefold
dilutions. Antigen binding was detected by staining with rabbit
anti-350 antiserum followed by GaR-FITC, and quantified by
fluorescence microscopy and computer-assisted image analysis as
described in Materials and Methods. As shown in Figure 4A,
FITC fluorescence in the presence of the cognate 350 antigen was
clearly visible relative to a non-cognate control antigen (142).
Under increased magnification (Figure 4B) the majority of the
fluorescent staining appeared localized to the perimeter of the
yeast-scFv particles, consistent with staining of the cell wall-
associated scFv. By eye, the LLD of the IFA format was 6.17 nM
(Figure 4A). To better quantify the LLD, we imaged three
separate, randomly chosen fields first by visible light and then with
FITC, to determine the percentage of total yeast-scFv particles
that exhibited antigen binding above a threshold value (Figure 4C).
By this approach, a LLD of 5.0-2.5 nM was observed. Although
somewhat less sensitive than the flow cytometry assays, the
immunofluorescence microscopy assay delivers useful sensitivity
without requiring flow cytometry.
Stability of lyophilized yeast-scFv
The stability of lyophilized yeast-scFv was assessed by using
clone 780-23 which is specific for 780-biotin antigen (Figure 5).
For each time point, an aliquot of lyophilized 780-23 yeast was
Figure 2. Pre- and post-lyophilization antigen binding and specificity of clone 350-E2. Fresh, non-lyophilized 350-E2 yeast and lyophilized,
rehydrated 350-E2 yeast were split into 10 aliquots. In Panel A, each aliquot received either no antigen, or 100 nM each of 350, 142, Jacob, or 780.
Biotinylated antigens were used in every case, and antigen binding was detected by incubating with SA-PE. Panel B was performed as in Panel A,
except that non-biotinylated antigens were used and antigen binding was detected by incubation with rabbit-anti-350 antiserum followed by GaR-
PE. The percent of PE-positive yeast was determined by gating the PE fluorescence relative to the ‘‘no antigen’’ control. Values are means of three
experiments plus or minus the standard deviation. The light grey bars indicate binding of the fresh yeast to each antigen, and the dark grey bars
indicate binding of the lyophilized yeast to the antigens.
doi:10.1371/journal.pone.0032042.g002
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then split into smaller aliquots. One aliquot was incubated with
100 nM 780-biotin (cognate antigen) and other aliquots were
incubated with 100 nM of three non-cognate antigens (Jacob-
biotin, 142-biotin, and 350-biotin). Jacob-biotin was used
throughout the experiment, while the other non-cognate antigens
were used only at later time points. After washing, the bound
antigen was detected by the addition of SA-PE. An aliquot of
unstained yeast was also analyzed as a negative control. As seen in
Figures 2 and 3, antigen binding was quantified using flow
cytometry to measure the percentage of yeast cells that expressed
scFv (FITC on the x-axis) and bound to biotinylated antigen (PE
on the y-axis). Binding activity was stable for at least 30 days, with
decay in the PE fluorescence starting around day 35. Binding to
non-cognate antigens was low throughout the experiment
(Figure 5).
Similar time course assays were carried out using clone 350-E2,
and both resulted in very similar trends. In this assay, binding to
cognate antigen (350-biotin) remained constant (between 40% and
60%) for $30 days post lyophilization, while binding to a non-
cognate control antigen (780-biotin) was low throughout the
experiment (Figure S2).
Discussion
Affinity reagents are critical limiting factors in biomedical
research and diagnostics. Our goal is to design faster, cheaper, and
more versatile methods for generating new affinity reagents. Yeast
display libraries of human scFv have been in use for more than 10
years and are well established for rapid in vitro antibody isolation.
However, the use of scFv culled from these libraries has been
limited by the slow and inefficient conversion of yeast-displayed
scFv to soluble, secreted antibodies that can be incorporated into
diagnostic tests. As a result, yeast display and related methods have
not supplanted traditional methods for generating monoclonal
antibodies.
To address this challenge, we pursued an alternative model for
yeast-scFv generation and application. We hypothesized that scFv
probes culled from yeast-display libraries would function best if
maintained in the environment in which they were selected,
namely tethered by Aga1-Aga2 linkages to yeast cell walls.
Accordingly, we developed methods to use yeast-scFv directly for
antigen detection, without requiring secretion of scFv in soluble
form. If enabled, the end-use detection reagents could be
generated in two to three weeks, much faster than MAb
generation.
We selected scFv that bound to cyst proteins derived from the
human pathogen E. histolytica. Four proteins were selected for this
study based on microarray analysis that indicated elevated mRNA
levels in cysts relative to trophozoites. The proteins were produced
recombinantly in E. coli and then biotinylated to perform selections
for yeast-displayed scFv Abs. Only one of the four proteins (142)
failed to yield specific yeast clones. While multiple clones were
selected to each of the other three proteins, the majority of clones
bound only to the biotinylated form of the proteins. We speculate
that biotinylation may alter protein folding, exposing new epitopes
not seen in the native protein. The selected yeast-scFv clones
bound the biotinylated form of the protein, and not to the biotin
entity itself, as indicated by the fact that they did not bind to
biotinylated non-cognate control antigens. One clone, Jacob-A11,
bound both unlabeled and Jacob-biotin protein, however it bound
much better to Jacob-biotin. Only two unique clones were isolated
that bound 350 antigen. This may be because the 350 protein
fragment used for selections was small (,18 kDa) and therefore
may have presented a small number of epitopes. One of these
clones, 350-E2, bound labeled and unlabeled 350 antigen equally
well and was isolated more than 20 times from multiple
independent selections. This clone was used for most of the
subsequent work.
A major goal of the study was to determine whether whole yeast
displaying scFv could be preserved by lyophilization. Yeast clones
were induced to express scFv on their surfaces, and then
lyophilized in single use aliquots. Microscopically, lyophilized/
reconstituted yeast were indistinguishable from freshly induced
yeast. By flow cytometry the rehydrated yeast exhibited much
lower side scatter fluorescence, suggesting that they lacked the
complexity/granularity of fresh yeast. The lyophilized yeast did
not form colonies when plated on SDCAA medium (synthetic
dextrose medium with casamino acids deficient in histidine, uracil,
and tryptophan). The loss of viability and shift in side scatter
fluorescence may be a result of our simple lyophilization protocol,
which did not use cryoprotectants. Our goal was not to maintain
viability, but rather to maintain the specific antigen binding
activities of the surface-displayed scFv.
In flow cytometric assays, clones maintained binding to cognate
antigen that was similar to that of freshly induced yeast.
Lyophilization did not increase non-specific binding to non-
cognate antigens. Lyophilized yeast-scFv probe 350-E2 bound to
its cognate antigen with a lower limit of detection (LLD) of less
than 1 nM. This LLD approaches that of a typical ELISA assay
using a monoclonal IgG antibody. In addition to flow cytometry,
diverse alternative read-outs can be used including the IFA
described here which detected 350 antigen with an LLD in the
range of 2.5–6.17 nM.
The lyophilized yeast were stored at room temperature,
reconstituted in simple buffers (typically PBS or PBS+5% BSA),
and were immediately usable following rehydration. Although
Figure 3. Lower limit of detection of 350 antigen by lyophilized
yeast-scFv clone 350-E2. Lyophilized 350-E2 yeast cells were
reconstituted in 1 mL YWB and split into 11 equal aliquots. Each
aliquot was incubated with 10 concentrations of 350-biotin antigen
ranging from 20 nM to 0.04 nM (plus the 0 nM control) in twofold serial
dilutions in 2.5 mL (total volume) YWB. Bound 350 antigen was
detected by incubating with a rabbit anti-350 antiserum followed by
goat-anti-rabbit-phycoerythrin (GaR-PE) detection. Samples were ana-
lyzed by flow cytometry. The entire experiment was repeated three
independent times, and each replicate was performed with an
individually grown, induced, and lyophilized 350-E2 clone. Each data
point shows the average mean percent PE-positive yeast plus and
minus the standard deviation.
doi:10.1371/journal.pone.0032042.g003
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course of 86 days and stained first for c-myc-FITC expression followed by staining with cognate 780-biotin or three non-cognate antigens (Jacob-
biotin, 350-biotin, or 142-biotin plus a no antigen control). Following detection of antigen binding with SA-PE, the percent of PE-positive yeast were
determined using the no antigen stain as a gating reference. The graph depicts the percent positive yeast (y-axis) at each of the time points tested
(x-axis) for each of the four antigens. The assay was terminated when binding to cognate 780-biotin antigen had dropped below 15%.
doi:10.1371/journal.pone.0032042.g005
Figure 4. Immunofluorescence assay using lyophilized yeast-scFv reagents. Panel A shows lyophilized, reconstituted 350-E2 yeast binding
to cognate 350 antigen (upper row) or non-cognate 142 (lower row) in concentrations ranging from 500 nM down to 0.69 nM in threefold serial
dilutions. Bound antigen was detected by incubating with a rabbit anti-350 antiserum followed by GaR-FITC detection. Stained yeast were viewed at
406magnification. Panel B is the 500 nM concentration of 350-biotin binding seen in Panel A, but photographed at 906magnification and digitally
zoomed 36 to visualize staining patterns. Panel C shows a graph of a second experiment in which 350-biotin was tested in triplicate using 11
concentrations ranging from 160 nM down to 0.14 nM in twofold serial dilutions. For each concentration, 3 fields were photographed twice, first in
visible mode, and then in FITC mode. The percent of FITC-positive yeast were calculated and graphed relative to the concentration of 350 antigen.
doi:10.1371/journal.pone.0032042.g004
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absorbers, and desiccants were not used, all three yeast-scFv clones
examined maintained stable binding for at least 30 days. Longer
shelf lives may be possible when yeast-scFv are stored with cooling
or desiccants.
Lyophilization of yeast-scFv facilitates storage and shipment.
Moreover, it abrogates the need for overnight growth of yeast in
SDCAA medium, followed by overnight induction of scFv
expression in SG/RCAA media, as well as the need to perform
quality control (QC) analysis of each induction. With lyophilized
yeast cultures, the QC is performed just once immediately prior
to lyophilization. A typical flow cytometry assay, such in Figure 2,
requires approximately 1e7 yeast. With lyophilization, liter-scale
batches of induced yeast (at a concentration of 2-4e7 yeast per
mL) can be stored in single-use aliquots of 1e7 yeast. This means
that a single 1-liter culture of induced yeast-scFv can yield
enough material for up to 4000 tests at a cost of a few pennies
per test.
Most of the assays describe herein utilized rabbit polyclonal
antisera for secondary detection of unlabeled antigens. We have
also used polyclonal mouse and chicken antisera for this purpose.
The use of polyclonal detection antibodies extends the time
required to generate functional yeast-scFv-based antigen detection
assays. However, polyclonal detection antibodies do not need to be
affinity-purified, because assay specificity is conferred by the yeast-
scFv, which are monoclonal. The only requirements for detection
antibodies are 1) that they bind to antigens of interest, and 2) that
they don’t cross-react with yeast-scFv in the absence of antigen.
Thus, polyclonal detection antibodies are inexpensive and easy
reagents to prepare.
In summary, whole-cell yeast-scFv affinity reagents can be
rapidly selected and prepared in lyophilized form. With its fast
turnaround time (3 weeks from expressed antigen to lyophilized
probe) and low cost, the process has the potential to routinely
overcome a significant bottleneck in diagnostics and research.
Materials and Methods
Reagents
Except where indicated, all chemicals were from Sigma-Aldrich
(St. Louis, MO). All secondary reagents for immuno-cytometry
were acquired through Molecular Probes (Invitrogen, Carlsbad,
CA). Nickel-NTA sepharose for purification of expressed antigens
was obtained from Qiagen.
The polyclonal rabbit anti-350 and anti-780 antisera were both
generated by Cocalico Biologicals, Inc., Reamstown, PA, USA).
Proteins 780, 350, 142, and Jacob were biotinylated using either
the Pierce EZ-Link Peg-Biotin or the Sulfo-NHS-LC-Biotin kit
(Thermo Scientific, Rockford, IL) per manufacturer’s instructions.
The degree of biotinylation was quantified using the Pierce Biotin
Quantitation (HABA) Assay (Thermo Scientific, Rockford, IL).
Protein purification
The divergent region of E. histolytica Jacob protein (compared to
E. dispar and E. moshkovskii proteins) was codon optimized
(GeneArt, Invitrogen) and topo-cloned into the pET SUMO
vector. The correct orientation of insert in pET SUMO vector was
verified by DNA sequencing.
For the chromodomain proteins (EHI_000780, EHI_115350,
and EHI_142000), DNA segments corresponding to the selected
region of proteins were PCR amplified from the E. histolytica
genomic DNA, digested with NdeI and BamH1 restriction enzymes,
gel-purified, and ligated to pET11a vector using the T4 DNA
ligase. Top10 cells were then transformed using the pET11a
vector containing the insert. Both pET SUMO vector and
pET11a vectors contain sequences for 6 histidine residues N-
terminal to the gene of interest, allowing each protein to be
purified using the Ni-NTA column according to the manufactur-
er’s instructions (Qiagen). The SUMO fusion protein was cleaved
from the EhJacob with the treatment of SUMO protease
(LifeSensors, Malvern, PA).
Library selections
Selections were performed as described previously [1,6,7,20].
Yeast were routinely grown in SDCAA broth. To induce
expression of scFv on the yeast surface, yeast were grown in
selective synthetic galactose/raffinose plus casamino acids deficient
in histidine, uracil, and tryptophan (SG/RCAA) broth. For round
1 (R1) and round 2 (R2) of selection, 10
10 yeast were incubated in
10 mL yeast wash buffer (YWB; PBS 0.5% BSA) containing
100 nM of each of the four biotinylated proteins separately. Yeast
that bound protein were then labeled by incubation with 200 mL
of either streptavidin-magnetic particles (R1) or anti-biotin-
magnetic particles (R2). Following the second magnetic sort, the
eluted yeast (R2 output) were incubated with 1 mgm L
21 SA-PE.
Yeast were then sorted by FACS for the top 10% of PE-positive
cells and expanded into 5 mL of SDCAA broth (sorted yeast
comprised the R3 output. For round 4 (R4) of the selection, the
R3a outputs were incubated with anti-c-myc MAb and goat-anti-
mouse- fluorescein isothiocyanate (GaM-FITC) to confirm
expression of scFv before again being incubated with 100 nM of
their specific biotinylated antigen followed by SA-PE. Yeast were
then sorted by FACS for FITC-positive and the top 10% of PE-
positive signal. Antigen-binding yeast were grown on synthetic
dextrose casamino acids minus His, Ura, Trp plate (-HUT media)
for single clone analysis. For each antigen, we picked 24–48 clones
and grew them in 96 deep well plates in 1 mL of SDCAA broth.
Following induction in 1 mL SGRCAA, each clone was then
tested by flow cytometry for binding to cognate antigen and for
non-binding to all non-cognate antigens or the secondary reagents
(SA-PE, FITC) themselves. Antigen-specific clones were then
amplified by PCR, and the PCR amplicon was subjected to BstN1
fingerprint analysis as described previously [6,7]. In this method,
the 850–1000 nucleotide PCR amplicons are digested with the
restriction endonuclease BstN1, usually resulting in 3–8 smaller
fragments. The resulting fragment pattern, or fingerprint, after
resolving the fragments by DNA gel electrophoresis is used to
determine uniqueness. All apparently unique clones were then
DNA sequenced to confirm uniqueness and confirmed clones were
used in the study.
To determine affinities, we used a previously described flow
cytometry assay which utilizes whole yeast [20,21,22,23]. In this
assay, yeast-displaying scFv were incubated with twofold serial
dilutions of biotinylated antigens spanning 3.125–250 nM in
concentration and antigen binding was determined by further
staining with SA-PE. Samples were analyzed by flow cytometry,
results graphed as a function of antigen-biotin concentration
versus mean PE fluorescence. Affinities were then determined by
using a nonlinear least squares fit of the curves as previously
described [1,21,24]. This assay was used to measure the affinities
of clones 780-23, Jacob-A11, 350-12, and 350-E2 (binding to 350-
biotin). The affinity of clone 350-E2 to unlabeled 350 was
measured by using a modification of this assay, in which binding
was detected by staining the yeast-antigen complexes with a rabbit
anti-350 polyclonal serum and then further stained with goat-anti-
rabbit PE. We did not test the affinity of clone Jacob-A11 to
unlabeled Jacob protein.
Lyophilized Yeast-scFv Probes
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e32042Yeast lyophilization
Selected yeast clones were induced to express scFv and active
antigen binding was confirmed as described above. Confirmed
antigen-binding cells were lyophilized by harvesting 100 mL of
SG/RCAA culture at an OD600=1.5–2 (1 OD600<2610
7 yeast/
mL). An aliquot of culture with ,1610
7 total yeast was transferred
to 1.5 mL freezer tubes and centrifuged for 1 min at 13000g. The
supernatant was decanted, and the pellets were flash-frozen in
liquid nitrogen for approximately 15 seconds. Without allowing
the yeast to thaw, the tubes were loosely capped and transferred to
a lyophilization beaker that had been previously cooled in a dry-
ice/ethanol bath. The beaker was immediately capped, fit to the
lyophilizer, and vacuum applied. Yeast were lyophilized overnight
using a Millrock Technology (Kingston, NY) Model BT48A
lyophilizer. Following lyophilization, tubes were tightly capped
and stored at room temperature without desiccants or stabilizers.
Specificity analysis
One aliquot of fresh, non-lyophilized 350-E2 yeast and one
aliquot of lyophilized, rehydrated yeast (,1610
7 yeast/aliquot)
were incubated with anti-c-myc MAb followed by goat-anti-mouse
FITC detection MAb to confirm expression of scFv. Following c-
myc staining, the yeast were split into two sets of five equal aliquots.
One set was incubated with 100 nM of biotinylated cognate
antigen and three biotinylated non-cognate antigens (plus the no
antigen control) for 1 hr at RT. Binding of biotinylated antigens
was detected by addition of 100 mL of a 1/800 dilution of SA-PE
for 30 minutes. The second set of aliquots received 100 nM of
unlabeled 350, 142, Jacob, and 780 (plus the no antigen control).
To detect binding of unlabeled antigens, the yeast were incubated
with a 1/1000 dilution of rabbit anti-350 antiserum for 45 min at
RT followed by a 1/800 dilution of goat-anti-rabbit-PE for 45 min
at RT. Yeast were then analyzed by flow cytometry for scFv
expression (x-axis; FITC fluorescence) and antigen binding ( y-axis;
PE fluorescence). The assay was performed three times, and each
assay utilized an independent induction and lyophilization of yeast
350-E2. The percent PE fluorescent yeast were determined by
gating the percent PE-positive relative to the ‘‘no antigen’’
controls. All other yeast clones isolated in this study were analyzed
for specificity in a similar fashion.
Lower limit of detection
One aliquot of lyophilized 350-E2 yeast clone was resuspended
in 1 mL YWB and split into 11 equal aliquots. Each aliquot was
incubated with 2.5 mL of 350 antigen ranging from 20 nM to
0.04 nM in twofold serial dilutions (plus the 0 nM control).
Following a 1 hour antigen incubation, yeast were washed to
remove unbound antigen, and the bound 350 antigen was
detected by incubating with a 1/2500 dilution of rabbit anti-350
antiserum. Final detection of bound 350 was achieved by
incubation with 1/2500 dilution of goat-anti-rabbit-PE (GaR-
PE) detection MAb for 1 hr. Samples were analyzed by flow
cytometry and the percent of PE-positive yeast, relative to a no
antigen control, were plotted versus the concentration of 350
antigen. The experiment was repeated three independent times,
and each data point reflects the average percent PE-positive yeast
plus and minus the standard deviation.
Immunofluorescence microscopy assay
One aliquot of lyophilized 350-E2 yeast clone was reconstituted
in 1 mL YWB and split into 8 equal aliquots. Each aliquot
received 100 mL of 7 concentrations of cognate 350 or non-
cognate 142 ranging from 500 nM to 0.69 nM in threefold serial
dilutions (plus the 0 nM control). Bound antigens were detected by
incubating with a 1/2500 dilution of rabbit anti-350 antiserum
followed by 1/800 dilution of goat-anti-rabbit-FITC (GaR-FITC)
detection MAb for 1 hr. Following three washes to remove
unbound antigen, yeast pellets were resuspended in 100 mL, and
10 mL of yeast were spotted onto microscope slides and a coverslip
applied. The yeast were imaged at 406 magnification using a
Nikon TE2000U inverted microscope (Nikon Corporation,
Tokyo, Japan) outfitted with phase contrast and DIC optics for
visible imaging, a FITC filter, a high speed Cool Snap CCD
camera, and a motorized stage for automated scanning. Image
capture and analysis was performed using Metamorph software
(Research Precision Instruments, Natick, MA).
To confirm staining of the perimeter of yeast, suggestive of scFv
binding, the sample incubated with 500 nM antigen was examined
at 906 magnification. For purposes of clarity, the image seen in
Figure 4B has also been digitally zoomed approximately 3-fold to
better discern the fluorescent staining pattern.
A second experiment was similarly performed to enumerate the
approximate number of FITC-positive yeast relative to a
concentration of cognate antigen. In this experiment, yeast were
incubated with 11 concentrations of unlabeled 350 antigen
ranging from 160 nM down to 0.16 nM in twofold serial dilutions.
For each antigen concentration, a minimum of 3 independent
fields were captured in visible mode followed immediately by the
same three fields in FITC fluorescence mode. Total and FITC-
fluorescent yeast were counted in each field using the Image J
Software (Rasband, W.S., ImageJ, U.S. National Institutes of
Health, Bethesda, Maryland, USA, imagej.nih.gov/ij/, 1997–
2011.) Visible fields were background-subtracted with a 50-pixel
rolling ball radius while sliding paraboloid was enabled and
automated smoothing disabled. Automatic thresholding was done
in grayscale with the default settings. Particles (cells) were analyzed
from 64-‘ without circularity compensation, with edge exclusion
and hole inclusion. Fluorescent (FITC) fields were background
subtracted in the same fashion. Then each FITC image underwent
a binary conversion allowing the watershed filter to be applied.
After automatic triangle thresholding in grayscale using a dark
background, the fluorescent particles were enumerated from 64-‘
without circularity compensation. In each field, percent fluores-
cence was calculated from the ratio of the number of fluorescent
yeast (FITC) to the total number of yeast in the visible spectrum.
The percentages were averaged and standard deviations calculated
from at least three fields at a given antigen concentration.
Lyophilization time course assay
To assess the stability of yeast-scFv following lyophilization, a
fresh culture of yeast clone 780-23 was induced for expression of
scFv and lyophilized in individual aliquots containing ,1610
7
yeast. For the first two weeks, time points were taken twice weekly,
and from then on time points were taken approximately once per
week until little binding to cognate antigen was observed.
For each time point, one aliquot of lyophilized yeast was
reconstituted in 1 mL YWB, stained for c-myc expression as
described previously, and then split into 5 equal aliquots. The
aliquots received 100 mL of 100 nM of one of either cognate 780-
biotin or non-cognate Jacob-biotin antigen (plus a no antigen
control). Following 45 min of antigen binding, yeast were washed
26 and bound antigen detected by incubation with a 1/800
dilution of SA-PE. Yeast were washed 36and analyzed for FITC
(x-axis) and PE ( y-axis) fluorescence by flow cytometry. A gate was
set to measure the total percent of PE-positive yeast relative to the
‘‘no antigen’’ control. The percent of antigen binding (percent PE-
positive) was then plotted versus the day post lyophilization. The
Lyophilized Yeast-scFv Probes
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non-cognate antigen was Jacob-biotin. Starting at day 30, we
included two other non-cognate antigens, 350-biotin and 142-
biotin to better assess specificity. The assay was terminated on day
86 when binding to cognate antigen had dropped below 15%.
Supporting Information
Figure S1 Pre- and post-lyophilization activity determi-
nation with multiple yeast-scFv clones. Yeast clones were
tested for their ability to bind antigen following lyophilization.
One hundred microliters of either fresh or lyophilized/rehydrated
yeast were stained first for c-myc-FITC expression (x-axis) followed
by binding to cognate antigen and to a non-cognate control
(100 nM antigen concentration). The name of the clone is
indicated on the far left column. The non-cognate and cognate
antigens used to generate the flow cytometric plots are indicated
on the right of the figure. Binding to antigen is indicated by an
increase in PE fluorescence ( y-axis). Clones 350-10 and 780-18 are
myc-negative due to premature stop codons following the scFv
gene. However, these clones appeared to bind antigen before and
after lyophilization.
(TIF)
Figure S2 Lyophilization time course assay with yeast-
scFv clone 350-12. Three individual colonies of clone 350-12
were lyophilized separately on different days. Every 3 to 5 days,
one aliquot of each was tested for binding to cognate antigen
(100 nM 350-biotin) and to a non-cognate control antigen
(100 nM 780-biotin) as described for Figure 5. The graph depicts
the binding to the cognate or non-cognate antigens, as determined
by percent of PE-positive yeast ( y-axis), for each of the time
periods tested (x-axis). Because of the staggered lyophilization
dates, data were grouped into groups of 2 to 3 days, and each
point represents the average and standard deviation for the day
range indicated in the graph.
(TIF)
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